Newcelx宣布FDA临床前会议成功,为Ncel-101启动1型糖尿病临床试验铺平道路

美股速递
Jul 01

Newcelx宣布,其与FDA就Ncel-101项目举行的临床前会议取得圆满成功,为推进该疗法针对1型糖尿病的临床试验明确了清晰的路径。此次会议成果标志着公司在该创新疗法的开发进程中迈出了关键一步。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10